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Introduction
Transition from childhood to adolescence is particularly
difficult in patients with chronic rheumatic diseases.
Moving from pediatric to adult assistance, is not an
administrative procedure; it involves a change from of
“child-centered” to an “adult-oriented” system, in a
delicate phase of life in which emotional stability has not
been achieved yet. A structure addressing medical,
psycho-social and educational adolescents needs is
therefore necessary, representing a link between adult and
pediatric rheumatology, in order to maintain the benefits
of treatment administered during in childhood.
Objectives
We report the experience of Young Adults Rheumatology
Outpatient of Florence taking charge of the patients in
this phase.
Methods
From January 2000 to May 2014, 754 patients were visited
at the Transition Outpatient: 41% with JIA; 16% arthralgia;
9% Raynaud’s phenomenon; 6% SLE; 3% scleroderma; 2%
connective tissue; 2% dermatomyositis; Acute Rheumatic
Fever (ARF) 2%; 1% autoinflammatory syndromes; 18%
others. Of the 311 patients with JIA (93M, 218F), 58.8%
had oligoarticular onset; 21.2% polyarticular; ERA 13.8%;
4.5% psoriatic arthritis and 1.6% systemic onset. Uveitis
was found in 29/311 patients, of which 76% with
oligoarthritis.
Results
147 patients, all with JIA, were evaluated for the involve-
ment of the temporomandibular joint that was noted in
73/147; of these, 29/73 are affected by oligoarticular JIA,
18/73 polyarticular, 15/73 ERA, 7/73 psoriatic and 4/73
systemic onset. 66/311 (21.2%) patients with JIA are trea-
ted with biologics: 32/66 etanercept, 27/66 adalimumab,
3 abatacept, 3 tocilizumab and 1 golimumab. The
prevalence of female gender is observed among patients
with Raynaud’s (76%) and SLE (91%). Of the 25 patients
with scleroderma, 22 (88%) had localized form, 3 (12%)
the systemic one. Out of the 13 patients with ARF (9M,
4F), 9 (69%) had cardiac involvement. Among the 134
patients defined as “others": 7 have Kawasaki Disease,
3 Takayasu and 3 PAN.
Conclusion
Our experience shows that over than 60% of JIA patients
had active disease despite biological therapy; all SLE
patients had active disease in varying degrees and require
therapy. Osteopenia/osteoporosis, chronic uveitis,
alterations in the TMJ required ongoing specialty care.
Contraception and pregnancy should be handled with
special care, in particular in SLE. It is crucial to work
closely with other specialists, common in our center. It is
necessary to assiduously support, understand and care of
these young patients to prevent therapy suspension, as
they frequently want to achieve independence from drugs
and become equal to healthy peers. It would desirable: 1)
to achieve a better collaboration between pediatricians and
adult rheumatologists for a gradual transition between the
two types of assistance; 2) to organize Transition
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Outpatients Clinics to make this transition less dramatic
and maintain adherence to therapy and disease control.
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